CRMD FY 2018 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$518M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$429,797+30.5% YoY

Gross Profit

$33,0117.7% margin

Operating Income

-$27M-6250.4% margin

Net Income

-$27M-6242.4% margin

EPS (Diluted)

$-1.51

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$19M

Total Liabilities

$14M

Stockholders' Equity

-$179M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$429,797	$329,327	+30.5%
Gross Profit	$33,011	$214,363	-84.6%
Operating Income	-$27M	-$33M	+18.4%
Net Income	-$27M	-$33M	+18.7%